Amgen (AMGN) Intangibles (2009 - 2026)

Amgen (AMGN) recorded quarterly Intangibles of $21.4 billion in Q1 2026, down 4.03% quarter-over-quarter from $22.3 billion in Q4 2025, and up 345.4% on a YoY basis from $4.8 billion in Q1 2025.

Amgen (AMGN) Intangibles (2009 - 2026) Analysis & Trends

Amgen's Intangibles history runs 18 years deep, the most recent figure standing at $21.4 billion for Q1 2026.

  • In Q1 2026, Intangibles rose 345.4% year-over-year to $21.4 billion; the TTM figure through Mar 2026 stood at $21.4 billion (up 345.4% YoY), while the FY2025 annual figure was $22.3 billion, down 19.58% from the prior year.
  • Intangibles was $21.4 billion for Q1 2026 at Amgen, down from $22.3 billion in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $32.6 billion in Q4 2023 to a low of $350.0 million in Q2 2025.
  • Historically, Intangibles has averaged $19.0 billion across 5 years, with a median of $16.1 billion in 2022.
  • The sharpest annual moves came in 2025 and 2026: Intangibles sank 98.84% in 2025, then soared 345.4% in 2026.
  • A 5-year view of Intangibles shows it stood at $16.1 billion in 2022, then surged by 102.99% to $32.6 billion in 2023, then declined by 15.14% to $27.7 billion in 2024, then dropped by 19.58% to $22.3 billion in 2025, then retreated by 4.03% to $21.4 billion in 2026.
  • The last three Intangibles figures came in at $21.4 billion (Q1 2026), $22.3 billion (Q4 2025), and $23.1 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 24.45 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 7.37 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 49.06 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 50.87 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 25.75 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 21.38 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 16.38 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 52.56 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 18.24 Bn
10 Novartis Ag 109.78 Bn 109.09 Bn - 10.60 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 21.38 Bn
Dec 31, 2025 22.28 Bn
Sep 30, 2025 23.14 Bn
Jun 30, 2025 350.00 Mn
Mar 31, 2025 4.80 Bn
Dec 31, 2024 27.70 Bn
Sep 30, 2024 28.92 Bn
Jun 30, 2024 30.17 Bn
Mar 31, 2024 31.37 Bn
Dec 31, 2023 32.64 Bn
Sep 30, 2023 13.15 Bn
Jun 30, 2023 14.63 Bn
Mar 31, 2023 15.39 Bn
Dec 31, 2022 16.08 Bn
Sep 30, 2022 13.27 Bn
Jun 30, 2022 13.93 Bn
Mar 31, 2022 14.57 Bn
Dec 31, 2021 15.18 Bn
Sep 30, 2021 14.66 Bn
Jun 30, 2021 15.31 Bn